Precipio, Inc. (PRPO) Form 10-Q — Aug 14, 2026
Precipio reported Q2 2026 net sales of $7.0 million, up 24% year over year, with gross margin improving to 45% from 43% as case volume rose 26% to 4,652 tests. Product revenue grew 45% to $0.9 million, though the quarterly net loss widened to $219 thousand from prior-year net income of $74 thousand. Despite the growth, the 10-Q carries going-concern language: Precipio has an accumulated deficit of $104.5 million, a $2.0 million operating loss for the first half of 2026, and management states substantial doubt remains about its ability to continue operating over the next twelve months, dependent on revenue growth and potential additional financing.
Key figures
- Revenue
- 7021000
- Revenue Yoy
- 24% (Q2 2026 vs Q2 2025); 30% for six months
- Cash Position
- 3075000
- Gross Margin Q2
- 45%
- Gross Profit Q2
- 3136000
- Working Capital
- 2836000
- Six Month Revenue
- 13732000
- Cases Processed Q2
- 4652
- Shares Outstanding
- 1790188
- Accumulated Deficit
- 104465000
- Case Volume Growth Q2
- 26%
- Gross Margin Six Months
- 43%
- Six Month Operating Loss
- -2000000
- Cases Processed Six Months
- 9564
- Top Customer Concentration
- Customer A: 30% of Q2 net sales, 37% of accounts receivable
- Case Volume Growth Six Months
- 42%
- Cases Processed Q2 Prior Year
- 3692
- Stock Options Granted Six Months
- 100000
- Erc Non Recurring Payments Prior18 Months
- 1200000
- Stock Options Weighted Avg Exercise Price
- $23.94
- Net Cash Provided By Operating Activities Six Months
- 724000
Price after filing
Close on the filing date to close N calendar days later (from $23.50). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.